{"entity":{"type":"insider","cik":"0001485088","url":"/insider/0001485088","json_url":"/insider/0001485088.json","name":"Last Andrew J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2010-08-24","last":"2024-09-10","span_basis":"filed_date"},"name_variants":[{"name":"Last Andrew J.","source":"filing","n_filings":10,"first_seen":"2010-08-24","last_seen":"2024-09-10"}],"transactions":[{"id":2432768,"accession":"0001062993-24-016386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-016386","line_url":"/filing/0001062993-24-016386#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":329.9384,"price_display":"329.94","price_state":"stated","total_value":989815.2,"total_display":"989,815.20","total_whole":"989,815","shares_owned_after":7559.4501,"shares_owned_after_display":"7,559.45","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":6274415,"accession":"0001493152-22-023524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-023524","line_url":"/filing/0001493152-22-023524#line-1","is_derivative":false,"issuer_cik":"0001485088","issuer_name":"Oncocyte Corp","issuer_ticker":"OCX","issuer_name_source":null,"issuer_url":"/issuer/0001485088","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.87,"price_display":"0.87","price_state":"stated","total_value":17400.0,"total_display":"17,400.00","total_whole":"17,400","shares_owned_after":70170.0,"shares_owned_after_display":"70,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":4615135,"accession":"0001062993-21-008244","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-008244","line_url":"/filing/0001062993-21-008244","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":813.10153,"price_display":"813.10","price_state":"stated","total_value":1626203.06,"total_display":"1,626,203.06","total_whole":"1,626,203","shares_owned_after":2531.9181,"shares_owned_after_display":"2,531.92","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":3},{"id":6888273,"accession":"0001493152-18-010761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-010761","line_url":"/filing/0001493152-18-010761#line-1","is_derivative":false,"issuer_cik":"0001485088","issuer_name":"OncoCyte Corp","issuer_ticker":"OCX","issuer_name_source":null,"issuer_url":"/issuer/0001485088","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6993.0,"shares_display":"6,993","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":6993.0,"shares_owned_after_display":"6,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-26","filed_date":"2018-07-31","scope":"insider"},{"id":5219088,"accession":"0001225385-17-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225385-17-000119","line_url":"/filing/0001225385-17-000119#line-1","is_derivative":false,"issuer_cik":"0001356090","issuer_name":"INTREXON CORP","issuer_ticker":"XON","issuer_name_source":null,"issuer_url":"/issuer/0001356090","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":24200.0,"total_display":"24,200.00","total_whole":"24,200","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider"},{"id":4717870,"accession":"0001225385-17-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225385-17-000102","line_url":"/filing/0001225385-17-000102#line-1","is_derivative":false,"issuer_cik":"0001356090","issuer_name":"INTREXON CORP","issuer_ticker":"XON","issuer_name_source":null,"issuer_url":"/issuer/0001356090","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":19.99,"price_display":"19.99","price_state":"stated","total_value":39980.0,"total_display":"39,980.00","total_whole":"39,980","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-15","scope":"insider"},{"id":8296251,"accession":"0001140361-15-013272","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-013272","line_url":"/filing/0001140361-15-013272#line-3","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110000.0,"shares_display":"110,000","price_per_share":12.79,"price_display":"12.79","price_state":"stated","total_value":1406900.0,"total_display":"1,406,900.00","total_whole":"1,406,900","shares_owned_after":170112.0,"shares_owned_after_display":"170,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-25","filed_date":"2015-03-26","scope":"insider"},{"id":3418785,"accession":"0001140361-12-035341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-035341","line_url":"/filing/0001140361-12-035341#line-1","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (EVP and GM, GABU)","role_mark":"O","role_mark_label":"Officer (EVP and GM, GABU)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and GM, GABU","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.06,"price_display":"4.06","price_state":"stated","total_value":40600.0,"total_display":"40,600.00","total_whole":"40,600","shares_owned_after":63907.0,"shares_owned_after_display":"63,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-03","filed_date":"2012-08-06","scope":"insider"},{"id":9100138,"accession":"0001140361-11-040630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-040630","line_url":"/filing/0001140361-11-040630#line-1","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.16,"price_display":"4.16","price_state":"stated","total_value":20800.0,"total_display":"20,800.00","total_whole":"20,800","shares_owned_after":58165.0,"shares_owned_after_display":"58,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider"},{"id":7707151,"accession":"0001140361-10-034832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-034832","line_url":"/filing/0001140361-10-034832","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001485088","owner_name":"Last Andrew J.","owner_display_name":"Last Andrew J.","owner_url":"/insider/0001485088","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.065,"price_display":"4.06","price_state":"stated","total_value":40650.0,"total_display":"40,650.00","total_whole":"40,650","shares_owned_after":45000.0,"shares_owned_after_display":"45,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-20","filed_date":"2010-08-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000012208","name":"BIO-RAD LABORATORIES, INC.","url":"/issuer/0000012208","role":"Officer (EVP, Chief Operating Officer)","n_filings":2,"first_seen":"2021-09-03","last_seen":"2024-09-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001642380","name":"Oncocyte Corp","url":"/issuer/0001642380","role":"Director","n_filings":2,"first_seen":"2018-07-31","last_seen":"2022-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001356090","name":"INTREXON CORP","url":"/issuer/0001356090","role":"Officer (Chief Operating Officer)","n_filings":2,"first_seen":"2017-08-15","last_seen":"2017-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000913077","name":"AFFYMETRIX INC","url":"/issuer/0000913077","role":"Officer (EVP, Chief Operating Officer)","n_filings":4,"first_seen":"2010-08-24","last_seen":"2015-03-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001485088","retrieved_at":"2026-08-23T10:54:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}